On October 14th, the Director and CEO for the French National Alliance for Life Sciences and Health, Gilles Bloch, visited Genomic Medicine Sweden, hosted by Karolinska Institutet´s President Ole Petter Ottersen. During the visit Gilles Bloch, Director of the French...
Vision Zero Cancer and Genomic Medicine Sweden (GMS) join forces with SciLifeLab, public sector authorities, regions, healthcare, academia, industry and patient organizations to create an innovation milieu that facilitates the introduction of more precise prevention...
The Swedish national infrastructure Genomic Medicine Sweden (GMS) will receive an additional SEK 220 million investment. The investment will facilitate the continued introduction of precision medicine into Swedish healthcare, so that every individual in Sweden has...
New review article looks at readiness prior to the implementation of genomics-based precision medicine in complex diseases. The extensive work has been led by researchers at Karolinska Institutet and Lund University and has been carried out together with some 30...
Over recent years, a large number of national and regional initiatives in the field of precision medicine have been established in Europe. In an overview published in Seminars in Cancer Biology, Genomic Medicine Sweden (GMS) and Centers for Personalized Medicine (ZPM)...
För att ge den bästa upplevelsen använder vi teknologier som cookies för att lagra och/eller få åtkomst till enhetsinformation. Genom att samtycka till dessa teknologier kan vi behandla data såsom surfbeteende eller unika ID:n på denna webbplats.
Anpassa samtycke
För att ge den bästa upplevelsen använder vi teknologier som cookies för att lagra och/eller få åtkomst till enhetsinformation. Genom att samtycka till dessa teknologier kan vi behandla data såsom surfbeteende eller unika ID:n på denna webbplats.
